Suvretta Capital Management, LLC Arcutis Biotherapeutics, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.33 Billion
- Q1 2024
A detailed history of Suvretta Capital Management, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 7,877,297 shares of ARQT stock, worth $75.6 Million. This represents 3.34% of its overall portfolio holdings.
Number of Shares
7,877,297
Previous 8,473,101
7.03%
Holding current value
$75.6 Million
Previous $27.4 Million
185.24%
% of portfolio
3.34%
Previous 1.42%
Shares
5 transactions
Others Institutions Holding ARQT
# of Institutions
172Shares Held
126MCall Options Held
498KPut Options Held
1.64M-
Jennison Associates LLC12.2MShares$117 Million0.08% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$84.3 Million4.57% of portfolio
-
State Street Corp Boston, MA8.78MShares$84.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY7.51MShares$72.1 Million2.54% of portfolio
-
Polar Capital Holdings PLC London, X06.89MShares$66.1 Million0.43% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $578M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...